159 related articles for article (PubMed ID: 9443087)
1. Mucoepidermoid carcinoma of the salivary gland--a clinico-pathologic and immunohistochemical study for c-erbB-2 oncoprotein.
Cho KJ; Kim JY; Lee SS; Oh KK
J Korean Med Sci; 1997 Dec; 12(6):499-504. PubMed ID: 9443087
[TBL] [Abstract][Full Text] [Related]
2. Amplification and overexpression of HER-2/neu in carcinomas of the salivary gland: correlation with poor prognosis.
Press MF; Pike MC; Hung G; Zhou JY; Ma Y; George J; Dietz-Band J; James W; Slamon DJ; Batsakis JG
Cancer Res; 1994 Nov; 54(21):5675-82. PubMed ID: 7522962
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical correlation of epidermal growth factor receptor and c-erbB-2 with histopathologic grading of mucoepidermoid carcinoma.
Khiavi MM; Vosoughhosseini S; Saravani S; Halimi M
J Cancer Res Ther; 2012; 8(4):586-90. PubMed ID: 23361279
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness.
Sugano S; Mukai K; Tsuda H; Hirohashi S; Furuya S; Shimosato Y; Ebihara S; Takeyama I
Laryngoscope; 1992 Aug; 102(8):923-7. PubMed ID: 1353853
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of MUC-1 has close relation with patient survivor in high-grade salivary gland mucoepidermoid carcinoma.
Siyi L; Shengwen L; Min R; Wenjun Y; Lizheng W; Chenping Z
J Oral Pathol Med; 2014 Sep; 43(8):579-84. PubMed ID: 24725122
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of p27 and Ki-67 expression in mucoepidermoid carcinoma of the intraoral minor salivary gland.
Okabe M; Inagaki H; Murase T; Inoue M; Nagai N; Eimoto T
Mod Pathol; 2001 Oct; 14(10):1008-14. PubMed ID: 11598171
[TBL] [Abstract][Full Text] [Related]
7. Mucoepidermoid carcinoma of minor salivary glands: a clinical study of 16 cases and review of the literature.
Triantafillidou K; Dimitrakopoulos J; Iordanidis F; Koufogiannis D
Oral Dis; 2006 Jul; 12(4):364-70. PubMed ID: 16792720
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronan and its receptors in mucoepidermoid carcinoma.
Wein RO; McGary CT; Doerr TD; Popat SR; Howard JL; Weigel JA; Weigel PH
Head Neck; 2006 Feb; 28(2):176-81. PubMed ID: 16355387
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in primary salivary gland mucoepidermoid carcinoma: an analysis of 376 cases in an Eastern Chinese population.
Liu S; Ow A; Ruan M; Yang W; Zhang C; Wang L; Zhang C
Int J Oral Maxillofac Surg; 2014 Jun; 43(6):667-73. PubMed ID: 24568836
[TBL] [Abstract][Full Text] [Related]
10. [Mucoepidermoid carcinoma of salivary glands: the prognostic value of tumoral markers].
Hoyek-Gebeily J; Nehmé E; Aftimos G; Sader-Ghorra C; Sargi Z; Haddad A
Rev Stomatol Chir Maxillofac; 2007 Dec; 108(6):482-8. PubMed ID: 17761202
[TBL] [Abstract][Full Text] [Related]
11. MUC4 and ERBB2 expression in major and minor salivary gland mucoepidermoid carcinoma.
Weed DT; Gomez-Fernandez C; Pacheco J; Ruiz J; Hamilton-Nelson K; Arnold DJ; Civantos FJ; Zhang J; Yasin M; Goodwin WJ; Carraway KL
Head Neck; 2004 Apr; 26(4):353-64. PubMed ID: 15054739
[TBL] [Abstract][Full Text] [Related]
12. Molecular differences in mucoepidermoid carcinoma and adenoid cystic carcinoma of the major salivary glands.
Gibbons MD; Manne U; Carroll WR; Peters GE; Weiss HL; Grizzle WE
Laryngoscope; 2001 Aug; 111(8):1373-8. PubMed ID: 11568571
[TBL] [Abstract][Full Text] [Related]
13. Mucoepidermoid carcinoma of the major salivary glands: clinical and histopathologic analysis of 234 cases with evaluation of grading criteria.
Goode RK; Auclair PL; Ellis GL
Cancer; 1998 Apr; 82(7):1217-24. PubMed ID: 9529011
[TBL] [Abstract][Full Text] [Related]
14. Expression of caveolin-1 in mucoepidermoid carcinoma of the salivary glands: correlation with vascular endothelial growth factor, microvessel density, and clinical outcome.
Shi L; Chen XM; Wang L; Zhang L; Chen Z
Cancer; 2007 Apr; 109(8):1523-31. PubMed ID: 17342767
[TBL] [Abstract][Full Text] [Related]
15. Salivary gland tumors: immunohistochemical study of EGF, EGFR, ErbB-2, FAS and Ki-67.
Ito FA; Ito K; Coletta RD; Graner E; de Almeida OP; Lopes MA
Anal Quant Cytol Histol; 2009 Oct; 31(5):280-7. PubMed ID: 20701095
[TBL] [Abstract][Full Text] [Related]
16. Salivary gland tumors in children and adolescents: a clinicopathologic and immunohistochemical study of fifty-three cases.
da Cruz Perez DE; Pires FR; Alves FA; Almeida OP; Kowalski LP
Int J Pediatr Otorhinolaryngol; 2004 Jul; 68(7):895-902. PubMed ID: 15183580
[TBL] [Abstract][Full Text] [Related]
17. HER2/neu and Ki-67 as prognostic indicators in mucoepidermoid carcinoma of salivary glands.
Nguyen LH; Black MJ; Hier M; Chauvin P; Rochon L
J Otolaryngol; 2003 Oct; 32(5):328-31. PubMed ID: 14974865
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of MUC1 predicts poor survival in salivary gland mucoepidermoid carcinoma.
Liu S; Ruan M; Li S; Wang L; Yang W
J Craniomaxillofac Surg; 2014 Dec; 42(8):1891-6. PubMed ID: 25187376
[TBL] [Abstract][Full Text] [Related]
19. Expression of cell adhesion molecule CD44 in mucoepidermoid carcinoma and its association with the tumor behavior.
Binmadi N; Elsissi A; Elsissi N
Head Face Med; 2016 Jan; 12():8. PubMed ID: 26821610
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor immunoexpression evaluation in malignant salivary gland tumours.
Monteiro LS; Bento MJ; Palmeira C; Lopes C
J Oral Pathol Med; 2009 Jul; 38(6):508-13. PubMed ID: 19317849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
